Structure-Based Design of Inhibitors Selective for Human Proteasome β2c or β2i Subunits

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1A unified mechanism for proteolysis and autocatalytic activation in the 20S proteasome2016 · 126 citations
2. 2Systematic humanization of yeast genes reveals conserved functions and genetic modularity2015 · 492 citations
3. 3Required Immunoproteasome Subunit Inhibition Profile for Anti-Inflammatory Efficacy and Clinical Candidate KZR-616 ((2<i>S</i>,3<i>R</i>)-<i>N</i>-((<i>S</i>)-3-(Cyclopent-1-en-1-yl)-1-((<i>R</i>)-2-methyloxiran-2-yl)-1-oxopropan-2-yl)-3-hydroxy-3-(4-methoxyphenyl)-2-((<i>S</i>)-2-(2-morpholinoacetamido)propanamido)propenamide)2018 · 103 citations
4. 4<i>REFMAC</i>5 dictionary: organization of prior chemical knowledge and guidelines for its use2004 · 1,415 citations
5. 5The catalytic sites of 20S proteasomes and their role in subunit maturation: A mutational and crystallographic study1999 · 307 citations